Literature DB >> 31449829

Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study.

Hashmat Ghanizada1, Mohammad Al-Mahdi Al-Karagholi1, Nanna Arngrim1, Mustafa Ghanizada1, Henrik Bo Wiberg Larsson2, Faisal Mohammad Amin1, Messoud Ashina3.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) has emerged as an important signaling peptide in migraine pathogenesis. Recently, we have shown that the less-abundant PACAP isoform, PACAP27, induced migraine and headache in patients equipotently to PACAP38. The present study examined the effect of PACAP27 on cerebral hemodynamics in healthy volunteers using high resolution magnetic resonance angiography (MRA). Eighteen healthy volunteers received infusion of PACAP27 (10 pmol/kg/min) or placebo over 20 min and were scanned repeatedly in fixed intervals for 5 h in a double-blind, randomized, placebo-controlled study. The circumference of extra-intracerebral arteries was measured and compared with PACAP38 data. We found significant dilation of middle meningeal artery (MMA) (p = 0.019), superficial temporal artery (p = 0.001) and external carotid artery (p = 0.039) after PACAP27 infusion compared to placebo. Whereas the middle cerebral artery (MCA) (p = 0.011) and internal carotid artery (ICA) (pICAcervical = 0.015, pICAcerebral = 0.019) were constricted. No effects on basilar artery (p = 0.708) and cavernous portion of ICA were found. Post hoc analyses revealed significant larger area under the curve for MMA after PACAP38 compared to PACAP27 (p = 0.033). We also found that PACAP27 induced headache in nine out of twelve (75%) volunteers and one (17%) after placebo. In conclusion, PACAP27 induced headache and dilated extracerebral arteries (>5 h) and slightly constricted MCA in healthy volunteers. Post hoc analysis of PACAP38 data compared with PACAP27 showed that PACAP isoforms dilates MMA with significantly different magnitude.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arterial dilation; Headache; PACAP receptors; PACAP27; PACAP38

Mesh:

Substances:

Year:  2019        PMID: 31449829     DOI: 10.1016/j.peptides.2019.170134

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  New discoveries in migraine mechanisms and therapeutic targets.

Authors:  Greg Dussor
Journal:  Curr Opin Physiol       Date:  2019-10-18

Review 2.  Targeting BKCa Channels in Migraine: Rationale and Perspectives.

Authors:  Mohammad Al-Mahdi Al-Karagholi; Christian Gram; Cherie Amalie Waldorff Nielsen; Messoud Ashina
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

Review 3.  Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide (Part 2): biology and clinical importance in central nervous system and inflammatory disorders.

Authors:  Terry W Moody; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-04-01       Impact factor: 3.626

Review 4.  Pituitary Adenylate Cyclase-Activating Polypeptide: A Potent Therapeutic Agent in Oxidative Stress.

Authors:  Nadia Sadanandan; Blaise Cozene; You Jeong Park; Jeffrey Farooq; Chase Kingsbury; Zhen-Jie Wang; Alexa Moscatello; Madeline Saft; Justin Cho; Bella Gonzales-Portillo; Cesar V Borlongan
Journal:  Antioxidants (Basel)       Date:  2021-02-26

5.  Design and Synthesis of Brain Penetrant Glycopeptide Analogues of PACAP With Neuroprotective Potential for Traumatic Brain Injury and Parkinsonism.

Authors:  Christopher R Apostol; Kelsey Bernard; Parthasaradhireddy Tanguturi; Gabriella Molnar; Mitchell J Bartlett; Lajos Szabò; Chenxi Liu; J Bryce Ortiz; Maha Saber; Katherine R Giordano; Tabitha R F Green; James Melvin; Helena W Morrison; Lalitha Madhavan; Rachel K Rowe; John M Streicher; Michael L Heien; Torsten Falk; Robin Polt
Journal:  Front Drug Discov (Lausanne)       Date:  2022-01-14

Review 6.  Brain barriers and their potential role in migraine pathophysiology.

Authors:  Astrid Wiggers; Håkan Ashina; Nouchine Hadjikhani; Abhay Sagare; Berislav V Zlokovic; Martin Lauritzen; Messoud Ashina
Journal:  J Headache Pain       Date:  2022-01-26       Impact factor: 7.277

7.  Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache.

Authors:  Hashmat Ghanizada; Mohammad Al-Mahdi Al-Karagholi; Nanna Arngrim; Mette Mørch-Rasmussen; Matias Metcalf-Clausen; Henrik Bo Wiberg Larsson; Faisal Mohammad Amin; Messoud Ashina
Journal:  J Headache Pain       Date:  2020-02-24       Impact factor: 7.277

8.  Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.

Authors:  Lanfranco Pellesi; Mohammad Al-Mahdi Al-Karagholi; Roberto De Icco; Hande Coskun; Fatima Azzahra Elbahi; Cristina Lopez-Lopez; Josefin Snellman; Jens Hannibal; Faisal Mohammad Amin; Messoud Ashina
Journal:  JAMA Netw Open       Date:  2021-08-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.